We are live on ! Find out more
BG

Bollard Group Portfolio holdings

AUM $3.39B
1-Year Est. Return 1.06%
This Fund
S&P 500
This Quarter Est. Return
+9.71%
1 Year Est. Return
-1.06%
3 Year Est. Return
+72.63%
5 Year Est. Return
+112.03%
10 Year Est. Return
+415.67%
AUM
$2.78B
AUM Growth
+$230M
Cap. Flow
+$22.2M
Cap. Flow %
0.8%
Top 10 Hldgs %
66.17%
Holding
474
New
12
Increased
104
Reduced
81
Closed
29

Top Buys

Rank Stock Value
1
DKNG icon
DraftKings
DKNG
+$19.2M
2
RKT icon
Rocket Companies
RKT
+$11.7M
3
DOCU
DocuSign
DOCU
+$6.11M
4
MTCH icon
Match Group
MTCH
+$5.91M
5
AKUS
Akouos Inc
AKUS
+$2.22M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$15M
2
PPLI
People Inc
PPLI
+$6.88M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$1.46M
4
LOW icon
Lowe's Companies
LOW
+$656K
5
BA icon
Boeing
BA
+$612K

Sector Composition

Rank Sector Weight
1 Healthcare 48.09%
2 Consumer Discretionary 11.55%
3 Communication Services 7.19%
4 Technology 6.8%
5 Utilities 6.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EFA icon
401
iShares MSCI EAFE ETF
EFA
$78.5B
$13K ﹤0.01%
208
– –
MCK icon
402
McKesson
MCK
$101B
$13K ﹤0.01%
84
– –
KIN
403
DELISTED
Kindred Biosciences, Inc.
KIN
$13K ﹤0.01%
3,129
-9,876
-76% -$41.3K
REZI icon
404
Resideo Technologies
REZI
$5.26B
$12K ﹤0.01%
1,074
– –
SGMO
405
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$12K ﹤0.01%
1,273
– –
PRTK
406
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$12K ﹤0.01%
2,159
-6,814
-76% -$33.7K
NPTN
407
DELISTED
NEOPHOTONICS CORP
NPTN
$12K ﹤0.01%
1,958
– –
ENLC
408
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$11K ﹤0.01%
4,836
– –
KDP icon
409
Keurig Dr Pepper
KDP
$43B
$10K ﹤0.01%
366
– –
SIEN
410
DELISTED
Sientra, Inc.
SIEN
$10K ﹤0.01%
308
-973
-76% -$36.9K
PFIE
411
DELISTED
Profire Energy, Inc
PFIE
$9K ﹤0.01%
12,822
-40,470
-76% -$31K
DELL icon
412
Dell
DELL
$262B
$8K ﹤0.01%
235
– –
JNCE
413
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$8K ﹤0.01%
1,009
-3,186
-76% -$19.8K
EWJ icon
414
iShares MSCI Japan ETF
EWJ
$22.1B
$7K ﹤0.01%
122
– –
MYO icon
415
Myomo
MYO
$38.6M
$7K ﹤0.01%
1,570
– –
ZBH icon
416
Zimmer Biomet
ZBH
$18.4B
$7K ﹤0.01%
50
– –
KODK icon
417
Kodak
KODK
$819M
$6K ﹤0.01%
+700
New +$5.47K
CTMX icon
418
CytomX Therapeutics
CTMX
$714M
$5K ﹤0.01%
712
-2,246
-76% -$16.7K
NBRV
419
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$5K ﹤0.01%
40
– –
ASIX icon
420
AdvanSix
ASIX
$555M
$4K ﹤0.01%
277
– –
TTOO
421
DELISTED
T2 Biosystems, Inc
TTOO
$4K ﹤0.01%
1
-1
-50% -$7.41K
GTX icon
422
Garrett Motion
GTX
$5.78B
$3K ﹤0.01%
778
– –
HPQ icon
423
HP
HPQ
$24.6B
$3K ﹤0.01%
165
+2
+1% +$36
OIH icon
424
VanEck Oil Services ETF
OIH
$2.01B
$3K ﹤0.01%
33
– –
ETTX
425
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$3K ﹤0.01%
1,448
-4,571
-76% -$13K
15 16
17
18 19

Similar funds

BCM
Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
EFM
E Fund Management Guangzhou, China $3.37B AUM
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return

Bollard Group's Q3 2020 Portfolio in Review

As of Q3 2020, Bollard Group held 474 positions worth $2.78B, up 9% from $2.55B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Bollard Group's Q3 2020 filing shows 12 new, 104 increased, 81 reduced and 29 closed positions. Its largest new stake was Rocket Companies: 500,000 shares worth $9.96M. The largest sale was Boston Scientific, an estimated $15M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 49% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Bollard Group's largest Q3 2020 buy was Rocket Companies: 500,000 shares worth $9.96M.
  • Bollard Group added most to DraftKings in Q3 2020, an estimated $19.2M increase.
  • Bollard Group's biggest Q3 2020 reduction was Boston Scientific, cutting an estimated $15M.
  • Bollard Group fully exited Charter Communications in Q3 2020, selling an estimated $469K.
  • Bollard Group's ten largest holdings make up 66% of its $2.78B portfolio in Q3 2020.
  • Bollard Group opened 12 new positions and closed 29 in Q3 2020.
  • Bollard Group's portfolio value rose 9% quarter-over-quarter to $2.78B.

Based on Bollard Group's 13F filing for Q3 2020, filed 12 Nov 2020.